NEUROCRINE BIOSCIENCES INC Insider Trading for November 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEUROCRINE BIOSCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEUROCRINE BIOSCIENCES INC for November 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | BENEVICH ERIC | Chief Commercial Of ... | Sell | S | 90.71 | 2,257 | 204,723 | 17,405 | 19.7 K to 17.4 K (-11.48 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | ROBERTS EIRY | Chief Medical Offic ... | Sell | S | 90.74 | 2,257 | 204,810 | 13,477 | 15.7 K to 13.5 K (-14.34 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lloyd-Smith Malcolm | Chief Regulatory Of ... | Sell | S | 90.73 | 2,257 | 204,776 | 29,002 | 31.3 K to 29 K (-7.22 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 90.72 | 2,257 | 204,755 | 30,082 | 32.3 K to 30.1 K (-6.98 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Sell | S | 90.73 | 2,257 | 204,784 | 81,624 | 83.9 K to 81.6 K (-2.69 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Sell | S | 90.78 | 3,390 | 307,748 | 441,071 | 444.5 K to 441.1 K (-0.76 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | Gano Kyle | Chief Business Deve ... | Sell | S | 90.73 | 2,257 | 204,770 | 98,028 | 100.3 K to 98 K (-2.25 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | Cooke Julie | Chief Human Resourc ... | Sell | S | 90.73 | 2,257 | 204,778 | 11,580 | 13.8 K to 11.6 K (-16.31 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 90.74 | 2,257 | 204,806 | 152,694 | 155 K to 152.7 K (-1.46 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 90.74 | 2,257 | 204,810 | 10,014 | 12.3 K to 10 K (-18.39 %) |
| Nov 04 2020 | NBIX | NEUROCRINE BIOSCIE ... | BENEVICH ERIC | Chief Commercial Of ... | Option Exercise | M | 35.99 | 20,595 | 741,214 | 7,775 | |
| Nov 04 2020 | NBIX | NEUROCRINE BIOSCIE ... | BENEVICH ERIC | Chief Commercial Of ... | Sell | S | 96.53 | 20,595 | 1,987,972 | 15,374 | 36 K to 15.4 K (-57.26 %) |
| Nov 04 2020 | NBIX | NEUROCRINE BIOSCIE ... | BENEVICH ERIC | Chief Commercial Of ... | Buy | M | 35.99 | 20,595 | 741,214 | 35,969 | 15.4 K to 36 K (+133.96 %) |